Those of us that have had severe neutropenia, either as a result of their CLL or from treatment for CLL and have been prescribed Neupogen to boost their neutrophil count, may find this Gizmag article of interest. "A drug long-used to counter the negative effects of chemotherapy has won US Food and Drug Administration (FDA) approval for use in treating the nasty effects of exposure to radiation following a nuclear disaster. Known commercially as Neupogen, the drug has been shown to work by shielding the body's white blood cells to heighten a patient's chances of survival." Scarily eye catch headlines and introductions aside, it's interesting to know that a commonly prescribed drug during CLL treatment has gained this approval:
gizmag.com/fda-drug-radiati...
Here's a bit more information about Neupogen:
chemocare.com/chemotherapy/...
The article mentions that filgrastim/neupogen can boost platelet production, of which I wasn't aware, but some further searching led me to this interesting article :
ncbi.nlm.nih.gov/pubmed/833...
So now those undergoing chemotherapy can be much more relaxed, knowing that they have a better chance of surviving a nuclear accident
Neil